{
  "primary": "ATXN3",
  "interaction_type": "indirect",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 2,
  "support_summary": "ATXN3 functionally interacts with TDP-43, a protein central to ALS and FTD pathology, by modulating its aggregation and cellular toxicity, though a direct binding interaction is not firmly established.",
  "functions": [
    {
      "function": "TDP-43 Aggregation",
      "arrow": "inhibits",
      "cellular_process": "ATXN3 functionally interacts with TDP-43, a protein prone to aggregation in neurodegenerative diseases like ALS and FTLD. This interaction modulates the aggregation process of TDP-43.",
      "effect_description": "ATXN3 is thought to influence the ubiquitination status and clearance of TDP-43, thereby reducing its propensity to form toxic aggregates. Dysfunction of ATXN3, particularly the polyQ-expanded form, may lead to an accumulation of pathological TDP-43 species.",
      "biological_consequence": [
        "ATXN3 modulates TDP-43 homeostasis → TDP-43 aggregation is reduced → Cellular toxicity is decreased"
      ],
      "specific_effects": [
        "TDP-43 is intrinsically aggregation-prone, and ALS-linked mutations can accelerate this process and increase toxicity.",
        "Pathological TDP-43 inclusions are hallmarks of ALS and FTLD."
      ],
      "evidence": [
        {
          "paper_title": "TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity",
          "year": 2009,
          "pmid": "19465477"
        },
        {
          "paper_title": "Which TDP-43 aggregates are toxic in ALS?",
          "year": 2015,
          "pmid": "27876701"
        }
      ],
      "_context": {
        "type": "indirect",
        "query_protein": null,
        "chain": []
      },
      "interaction_effect": "regulates",
      "direction": "main_to_primary",
      "interaction_direction": "main_to_primary",
      "pathway": {
        "name": "Protein Folding and Aggregation",
        "canonical_name": "Protein Folding And Aggregation",
        "ontology_id": null,
        "ontology_source": null,
        "confidence": 0.8
      },
      "pmids": [
        "19465477",
        "27876701"
      ],
      "function_effect": "inhibition",
      "arrow_context": {
        "direct_from": null,
        "direct_arrow": "inhibits",
        "net_from": "ATXN3",
        "net_arrow": "inhibits",
        "mediator_chain": [],
        "is_indirect": true
      },
      "net_arrow": "inhibits",
      "direct_arrow": "inhibits",
      "net_effect": "inhibition",
      "direct_effect": "inhibition"
    }
  ],
  "arrow": "regulates",
  "direction": "primary_to_main",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "inhibits"
    ]
  },
  "_chain_inferred": true,
  "mechanism": "ATXN3 functionally interacts with TDP-43, a protein prone to aggregation in neurodegenerative diseases like ALS and FTLD. This interaction modulates the aggregation process of TDP-43.",
  "effect": "ATXN3 is thought to influence the ubiquitination status and clearance of TDP-43, thereby reducing its propensity to form toxic aggregates. Dysfunction of ATXN3, particularly the polyQ-expanded form, may lead to an accumulation of pathological TDP-43 species.",
  "summary": "ATXN3 inhibits TDP-43 to modulate tdp-43 aggregation, ultimately affecting cellular toxicity is decreased.",
  "evidence": [
    {
      "paper_title": "TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity",
      "year": 2009
    },
    {
      "paper_title": "Which TDP-43 aggregates are toxic in ALS?",
      "year": 2015
    }
  ],
  "pathways": [
    {
      "name": "Protein Folding and Aggregation",
      "canonical_name": "Protein Folding And Aggregation",
      "ontology_id": null,
      "ontology_source": null,
      "confidence": 0.8
    }
  ],
  "interaction_effect": "regulation",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 2
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 --regulates--> TDP-43:",
  "protein_a": "TDP-43",
  "protein_b": "ATXN3",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-12-08T02:27:47.357942Z",
  "last_updated": "2025-12-08T02:27:47.357942Z"
}